Old Age An Incurable Disease Health And Social Care Essay

Health is a central issue and fundamental human right associated with increase in longevity of population ageing. The maintenance of health status and functioning with age is a critical factor impacting upon many other aspects of the lives of aged, their family and communities.

Ageing is a natural process which is inevitable and thus being the end of the human life cycle. Perceiving ageing with fear is recent phenomenon, it seems to be increasing each day, as world become more complex and moreover ageing is associated with decline in functional ability which affects all aged peoples. Aged have limited regenerative abilities and more prone to disease, syndrome and sickness than adults.

“Old age is an incurable disease,

You do not heal old age but

You protect, promote and extend it”. – James Sterling Ross

The number of persons above the age of 60 years is fastly growing, especially in India. India is the second most popular country in the world has 76.6 million people at over the age of 60, constituting above 7.7% of total population. The most obvious manifestations of old age are changes in physical appearance such as wrinkles appearing on the face, graying of hair, restriction of movements and more prone to chronic illness. Too frequently, older adults suffer from the emotional side effects of ageing such as feeling of distress and anxiety regarding their future, loneliness and social isolation. The major area of concern is the health of the aged with multiple medical and psychosocial problems which have an impact on functional ability of aged.

Functional disability in the aged is defined as an acquired difficulty in performing basic everyday tasks or more complex tasks needed for independent living Davidson. (2011).

The most common problem confronting aged people is functional disability that leads to dependency and institutionalization. The functional disability in the aged includes three dimensions: physical, emotional, and mental performance.

The population of functionally disabled aged is growing rapidly. The number of aged who suffered with functional disability due to arthritis, stroke, cognitive impairment, anxiety and emotional distress is expected to increase at least 80 percent by 2049.

Functional disability limits the autonomy of older people, introduces dependence, and reduces the quality of life and increase the risk of nursing home admission. Studies have shown that the proportion of aged persons who cannot move and are confined to their bed or home ranges from 77 per 1000 in urban area and 84 per 1000 in rural areas.

The family and community play a vital role in the care of a functionally disabled aged. The supportive care for aged with functional disability is the major concern which includes early rehabilitation with adequate nutrition, fluids, range of motion exercise, second hourly position changing; skin care and reviewing medical follow up. This will enable to prevent the development of complications such as infection, bed sore, constipation, movement incapability, urinary tract infection, deep vein thrombosis, muscle atrophy and contractures with resultant deformity in the aged.

Studies shown that majority (70%) of the aged over 60 years with functional disability are expecting the need of care by the caregivers to perform their daily activities. Caregivers are the one who is always present with the aged client, satisfying their needs and solving their problems. The caregivers of the aged may be their spouse, childrens or some other paid caregivers. The involvement of caregivers in caring the aged ones has been a help to create a great confidence in the aged to perform some kind of activities of daily living and also it has profound effect on aged reaction to medical treatment, emotional adaptation and rehabilitation. To implement the care for aged it is necessary that caregivers must be aware of functional disability in the aged to provide supportive care.

BACKGROUD OF THE STUDY:

By reviewing the bureau report 2009, globally aged population will increase from 595 million to 2 billion, a four fold rise by 2050, in terms of proportion 10% in 2000, 15% by 2025 and rise to 21.6 % by 2050.

Ageing population is an end product of demographic transition, the number of older adults aged above 60 years is increasing and they are becoming larger percentage of over all population.

In India, it is estimated that the elderly population has grown from 12.6 million in 1901 to 80.93 million in 2010 and India is the second largest country comprising aged in the whole world and is likely to touch 300 million within next half century. Data available from India suggest that almost 50 per cent of the elderly suffer from chronic diseases with the prevalence of diseases increasing with rising age from 39 per cent in 60-64 years to 55 per cent in those older than 70 years.

Research by the National institute of ageing reports that 80% of the aged are living with chronic conditions. Most of them are able to meet their own needs but only 25% of them require a special type of care. More than two third of the aged (22 %) live independently in a family setting. It is estimated that 10% of the aged need some form of long term care in the home.

Prevalence of various functional disabilities gradually increases with advancing age, starts at the age of 60 years and cause a growing need for help especially after the age of 65 years. Ageing process and changes in life style pattern such as chronic alcoholism, smoking, use of tobacco, sedentary life style, obesity, lack of exercise and improper nutrition during the young age has led a risk of chronic disease conditions among elderly population which results in 70% of disability making elderly more dependent on family and caregivers.

Eden. (2000) stated that old age is still perceived as a casual agent for seeking dependence in performing daily activities and the factors frequently causing dependency are age, gender, falls, illness etc.

A large population of today’s ageing is dependent on the family members for their health maintenance. Approximately 54% of the aged above 60 years are dependent, 24% of them are partially dependent and 22% of them are independent in performing their daily activities. The dependence on others for meeting the various needs will generate a felling of physiological and psychological dependence among the aged. The prevalence of unmet needs for functional disability in the aged due to vision problems is about 4.3%, 22.6% due to hearing problem, 32.5% due to immobility, 50% due to cognitive impairment, 62% due to difficulties in activities of daily living, 35% due to chronic illness, 25% due to psychological and social problems among those aged 60 and older.

The involvement of caregivers in caring the aged will help to create a great confidence in aged to perform some kind of activities of daily living. Approximately 4.1 million caregivers are involved in intense care giving. Hence the care giving is not only the responsibility of health professionals but also the family members, relatives, friends and even non- professionals who cares for the aged in home.

NEED FOR THE STUDY:

Advances in technology and the combination of high fertility and declining mortality in twentieth century have resulted in rapid and large number of aged people worldwide especially in developing countries. In every country, the proportion of people aged over 60 years is growing faster than any other age group.

Ageing causes numerous changes in the physiology of human beings which decreases functional ability. This in turn makes them dependent on caregiver. Inadequate care results in falls and depression among older adults.

Among the aged, the focus is not only on reducing disease related morbidity and mortality, but also on promoting optimal health and ensuring disability-free years. The literature states that the effect of functional disability will have an effect on quality of life among aged, as the aged become dependent where the caregivers should play a major role in taking care of such aged person. Caregivers are the one who is always present with the aged client, satisfying their needs and solving their problems. It is necessary that caregivers must be aware of functional disability in the aged to provide supportive care.

Investigator, during her clinical posting and community postings came across many aged with functional disability such as loss of control in body movements, functional immobility and associated coexisting illness who were dependent on their caregivers for their daily activities. While interacting with their caregivers the investigator came to know that they are not having adequate knowledge regarding the effects of functional disability and the care needed for the aged. Investigator felt that, aged with functional disability need some form of long term care in the home. If the caregivers had the knowledge they would help the aged in taking care of their health to prevent further complications. So the investigator felt the need to assess the knowledge regarding functional disability in the aged and its supportive care among caregivers to develop insight on the needs of older adults.

STATEMENT OF THE PROBLEM:

A study to assess the knowledge on functional disability in the aged and its supportive care among caregivers at selected settings in Chennai

OBJECTIVES:

To assess the knowledge on functional disability in the aged and its supportive care among caregivers at selected settings in Chennai.

To associate the knowledge regarding functional disability in the aged and its supportive care with selected demographic variables among caregivers at selected settings in Chennai.

OPERATIONAL DEFINITIONS:

ASSESS: In this study assess refers to the process of gathering information as expressed by the caregivers in response to the semi-structured interview schedule and analyzing it with the statistical method.

KNOWLEDGE: In this study knowledge refers to the awareness about functional disability and its supportive care as expressed by caregivers as response to the semi-structured interview schedule and analyzing to the statistical method.

AGED: In this study the aged refers to the people above 60 years who are available in the hospital and community.

CAREGIVERS: In this study the caregivers refers to the family members, relatives and paid non – professional persons in the age group from 21 years to 65 years who are taking care of the aged.

FUNCTIONAL DISABILITY: In this study the functional disability refers to deviations from the normal or customary function of an individual within any of the three dimensions i.e, physical, emotional or social skills necessary for an independent life.

SUPPORTIVE CARE: In this study the supportive care refers to the care which is provided to support the functionally disabled aged in meeting their daily needs.

SETTINGS: In this study setting refers to the place or type of surroundings from where the sample is collected i.e, community and hospital setting.

ASSUMPTIONS:

The knowledge on the functional disability in the aged and the supportive care among the caregivers will vary from adequate to inadequate.

The knowledge on functional disability in the aged and the supportive care among caregivers will be influenced by the selected demographic variables.

DELIMITATION:

The samples are the caregivers of the aged available in the community setting i.e, Thoraipakkam, Navalur and those admitted to the two hospitals i.e, V.H.S multi speciality and Dr.Kamakshi memorial hospital. Period of data collection is limited to one month.

PROJECTED OUTCOME:

The results of the study will project the knowledge levels of whom regarding various functional disabilities in the aged and the supportive care needed.

The knowledge levels will highlight the need for educating the caregivers on various problems of functional disability

By assessing this need, we can formulate the various methods of educating the caregivers on common problems of functional disability and it supportive care in the aged.

CONCEPTUAL FRAMEWORK

A concept is an image or symbolic representation of an abstract idea. Conceptual frameworks are interrelated concepts or abstractions that are assembled by virtue of their relevance to a common theme Polit and Beck (2001). It is a device that helps to stimulate research and the extension of knowledge by providing both direction and impetus. A framework serves as a spring board for scientific advancement.

A conceptual framework serves as a guide, to identify systematically and precisely defined relationship among the variables. It gives an idea to the main view and common theme of the research that is a visual diagram by which the researcher explains the area of interest.

MODEL:

The conceptual framework adopted for the study is based on “PENDER’S HEALTH PROMOTION MODEL (1987)”.

Health promotion is, “directed towards increasing the level of well being and self actualization in a given individual or group”.

This model focuses on the three aspects,

Modifying factors.

Cognitive perceptual factors.

Participating in health promoting activities.

MODIFYING FACTORS:

It refers to the situational, maturational, socio cultural, personal and biological factors.

In this study, it refers to the demographic variables like age, gender, marital status, educational status, occupational status, family income, type of family, any previous experience of taking care of the aged, relationship with the client, history of any present diseases in aged person, degree of physical dependency, hours spent in the care of the aged person, any previous information on functional disability in the aged and its supportive care.

COGNITIVE PERCEPTUAL FACTORS:

In this model, cognitive perceptual factors have important motivational significance. These variables can be modified through nursing actions.

In this study it refers to the knowledge of caregivers regarding functional disability in the aged and its supportive care in the aspects of disability in the aged, vision problems, hearing problems, loss of control in body movements, memory impairment , functional immobility, activities of daily living, importance of exercises, coexisting illness, psychological problems and family support.

PARTICIPATING IN HEALTH PROMOTING ACTIVITIES:

Participation of caregivers in this study is considered as one of the health promoting behavior as this will help the caregivers to be aware of their existing knowledge on functional disability in the aged and its supportive care, which enhance through the advices given.

CUES FOR ACTION:

The responses of the caregivers regarding their knowledge on functional disability in the aged and its supportive care provide cues for nursing action like reinforcement and also creating awareness in terms of early rehabilitation of functionally disabled aged with adequate nutrition, fluids, range of motion exercise, second hourly position changing; skin care, reviewing medical follow up, providing assistive devices, assisting in daily activities, emotional support, engaging in social activities, promoting comfort and psychological support.

MODIFYING COGNITIVE PERCEPTUAL PARTICIPATING IN HEALTH

FACTORS FACTORS PROMOTING BEHAVIOUR

KNOWLEDGE OF CAREGIVERS REGARDING FUNCTIONAL DISABILITY IN THE AGED AND ITS SUPPORTIVE CARE:

Information regarding health promoting behavior includes,

Disability in the aged

Vision problems

Hearing problems

Loss of control in body movements

Memory impairment

Functional immobility

Activities of daily living

Importance of exercises

Coexisting illness

Psychological problems

Family support

Participation of caregivers in the study and sharing information regarding functional disability in the aged and its supportive care

DEMOGRAPHIC VARIABLES:

Age

Gender

Marital status

Educational status

Occupation

Family income

Type of family

Relationship with the client

Any previous experience of taking care of the aged

Hours spent in the care of the aged person

Any previous information on functional disability in the aged and its supportive care

History of any present diseases in aged person

Degree of physical dependency

Reinforcement

Adequate knowledge

Eliciting the knowledge of caregivers regarding functional disability and its supportive care through semi-structured interview schedule

Moderate knowledge

Inadequate knowledge

Cues for nursing action

FIG.1 CONCEPTUAL FRAMEWORK BASED ON PENDER’S HEALTH PROMOTION MODEL (1987)

CHAPTER II

REVIEW OF LITERATURE

Review of literature aids the researcher to understand what already known in relation to problem of interest and what remains to be known. It helps to plan and conduct the study in a systematic manner. It is defined as reviewing and analyzing the work of literature in relation to the specified topic in research – Simai Haji Mati.

This chapter deals with selected studies and articles which are related to the objectives of the proposed study. For the present study an extensive review of literature relevant to study was undertaken and is presented under the following headings.

Part I: General information about ageing, functional disability in and its supportive care.

Part II: Studies related to functional disability and its supportive care in the aged.

Part III: Studies related to knowledge of caregivers of aged on functional problems and its supportive care.

Part I: General information about ageing, functional disability and its supportive care.

Ageing is the process of optimizing opportunities for health, participation and security in order to enhance quality of life as people age. It applies to both individuals and population groups. Ageing allows people to realize their potential for physical, social, and mental well-being throughout the life course.

According to Stephan John. (2009) Ageing is denoted as,

Young old – 65-74 yrs.

Middle old – 75-84 yrs.

Older old – 85 and older

Darnton. (1995),emphasized that quality of old age people depends mainly on psychological well being, perceived health status with independency in meeting self care needs.

Normal Ageing process:

The ageing process creates profound changes that there will be 1-2% decline in functional ability per year. Normal Ageing brings about the changes in physiological, Social and Psychological well being – Judith A. McCann. (2003)

Physiological aging process:

Changes in body composition, reduction in bone mass and strength, reduction in blood volume, reduced motility of the large bowel, changes in autonomic function, reduced elasticity of eye lens, high tone hearing impairment and reduced motor and sensory function.

Social and psychological aging process:

Feeling of distress, anxiety regarding their future, loneliness, depression, grief, sadness, and social isolation.

However, some of the above effects of ageing can be slowed by engaging in interventions that improves outcome in the health events.

Functional disability in the aged is defined as an acquired difficulty in performing basic everyday tasks or more complex tasks needed for independent living. It is an important health indicator in the aged, jeopardizing quality of life and causing heavy social impact with long-term institutionalization and increased use of medical care.

Reducing functional disability in the aged is a major challenge for public health- Frazil.(2005), performance in functional disability includes three dimensions: physical, emotional, and mental performance. Physical performance relates to the body’s sensory and motor function. Emotional performance is measured through the individuals’ adaptation to various events in their lives. Mental performance is evaluated through tests that measure the individuals’ intellectual and rational capacity.

The causative factors for functional disability are as follows:

Vision problems, hearing problems, loss of control in body movements, memory impairment, functional immobility, difficulties in performing daily activities, lack of physical exercises, coexisting illness, psychological problems and family support.

The effects of fundamental disability include walking, lifting objects, climbing stairs, reading standard-size print and hearing disturbances, short-term memory loss, disturbance in daily activities, disorientation to time and place, reducing mobility and social activities. The care necessary for the effects of functional disability are early rehabilitation with adequate nutrition, fluids, range of motion exercise, second hourly position changing; skin care, reviewing medical follow up, providing assistive devices, assisting in daily activities, emotional support, engaging in social activities, promoting comfort and psychological support.

By over viewing the various informations regarding functional disability in the aged will thereby helps the caregivers to prevent further complications and also provide supportive care for the aged.

Part III: Studies related to functional disability and its supportive care in the aged.

Felix. (2001) stated that disability is systemic; no body system is immune to its effect. From his statement it is evidenced that meeting the self care activities and physical maintenance are essential for managing the effects of disability.

Nandi Manju. (2002) stated that as ageing increases there will be decline in functional ability, which is compromised with good nutrition, assistive support, with psychosocial concerns and with medical care.

Steffen Been. (2005) proposed a statement that there will de decline in cognitive and functional abilities of old age due to continuous degeneration of numerous brain cells which aid them to obtain a fully dependable care from caretakers.

Frey. (2006) stated that decreased level of physical activity and growing number of chronic illness that often increase with age, frequently create vicious circle of illness, and related functional disabilities that has adverse effect on activities of daily living. In this statement, he highlighted that decrease in functional ability makes the individual to become more dependent and need constant support and supervision.

McDougall.(2006) conducted a cohort study to identify the prevalence of memory impairment among 265 older adults by means of survey method and the results showed that 29.4% (78 individuals) of them had memory impairment in the later adult period .He also concluded that those with declining memory are less aware of their deficits in meeting activities of daily living.

Human research center for ageing.(2006) stated that immobilization, loss of control in body movements and falls need not to be the consequence of living to advanced age all this may be prevented through muscle strengthening and range of motion exercise which has reported benefits of spontaneous activity by the old age people.

Stark.et.al.(2007) conducted a correlational study to assess the health status of functionally disabled aged under the supervision of institution and family by means of health indicator assessment scale and the results showed that the older adults who receiving the care such as adequate nutrition, fluids, range of motion exercise, second hourly position changing, skin care, reviewing medical follow up and participating in family activities are in the family are having moderate health status than the older adults in the institutionalized care.

Zbylut j. (2007) conducted a national survey to evaluate the health status of older persons and prevalence of common health problems among elderly above 60 years. The survey results shows that a large number of older persons were suffering from one of more age-associated chronic diseases like osteoporosis, osteoarthritis, dental problems, visual problems, cognitive impairment and depression which may impair their functional ability and quality of life.

Kart berg. et.al (2010) conducted a descriptive study to assess the functional ability among the aged by means of questionnaire in the aspects of physical, mental and social abilities and the study concluded that low functional ability lead to dependency and stressful environment for the aged which again increase the risk of complications.

Lawton and Brody.(2010) described that assessment of functional ability often includes evaluation of individuals ability to carry out activities of daily living which is an early sensitive indicator to promote quality of life of old age people.

From the above studies the investigator identifies the prevalence, impact of functional disability in the aged and the important aspects of supportive care for the aged. It helped to formulate the need for the study and also helped to identify the major areas which should be included while formulating the objectives.

Part IV: Studies related to knowledge of caregivers of aged on selected functional problems and its supportive care.

Skalska.et.al. (2007) conducted a cohort study with the aim to evaluate the knowledge on various areas of functional problems among 62 caregivers of aged at risk by means of questionnaire and the samples are (78% family members and 22% non related) results revealed that only 41% caregivers had knowledge on functional problems such as (vision, hearing, and memory problems in the aged) and 59% were not aware of functional problems mainly in cognitive and social problems.

Chelma.et.al. (2009) conducted a explorative study to identify the measures on management of functional problems of elderly among 629 caregivers by means of check list, the result revealed that 47% of them were aware on the common measures and 53% were unaware on common measures on management of functional problems among elderly.

Through these studies the investigator understands the importance of caregivers awareness on functional disability in the aged and its supportive care which helped me to formulate the tool.

CHAPTER – III

METHODOLOGY

This study was undertaken to assess the knowledge on functional disability in the aged and its supportive care among caregivers at selected settings in Chennai.

This chapter on methodology includes research approach, research design, setting, population, criteria for selection of sample, sample size, sampling technique, data collection tool, development and description of the tool, validity of the tool, pilot study, data collection procedure and plan for data analysis.

RESEARCH DESIGN

A non experimental descriptive design was chosen for this study.

RESEARCH APPROACH

Research approach was descriptive in nature.

SETTING OF THE STUDY

The setting of the study was chosen on the basis of feasibility, in terms of availability of adequate samples from hospitals and community.

Voluntary Health Services Hospital, Adyar, Chennai.

Dr.Kamakshi Memorial Hospital, Pallikaranai, Chennai.

Community- Thoraipakkam and Navalur.

POPULATION FOR THE STUDY

The population of the study consists of the caregivers of the aged in selected hospitals and in the community.

SAMPLE OF THE STUDY

The caregivers of the aged within the selected hospital and in the community who have fulfilled the inclusion criteria.

CRITERIA FOR THE SELECTION OF SAMPLES

Inclusion criteria:

The caregivers who are taking care of the aged with functional disability.

The caregivers in the age group of above 20 yrs.

Both male and female caregivers of aged people.

Caregivers who are willing to participate.

Exclusion criteria:

The caregivers who are included in the pilot study.

The caregivers of the aged who are independent in doing their daily activities.

Care givers who do not understand and communicate in Tamil or English.

SAMPLE SIZE

The sample size of this study is 60 caregivers of the aged people at selected settings, Chennai.

SAMPLING TECHNIQUE

Purposive sampling technique is used in this study.

DATA COLLECTION TOOL

The data was collected from the caregivers using semi-structured interview schedule.

DESCRIPTION OF THE TOOL

The tool prepared in this study was based on the information gathered from the review of literature; objectives of the study and the personal and professional experience of the investigator. It consists of two parts

Part – I: It consists of demographic variables like age, gender, marital status, educational status, occupation, family income, type of family, any previous experience of taking care of the aged, relationship with the client, hours spent in the care of the aged person, any previous information on functional disability and supportive care, history of any present disease in aged person and degree of physical dependency of the aged.

Part – II: It consists of 11 questions which have three parts to assess the knowledge on functional disability in the aged and its supportive care among caregivers using semi-structured interview schedule.

SCORING PROCEDURE:

In part II:

In first question, part (A) the correct option carries one mark; the incorrected option carries zero mark. In part (B) each option carries one mark.

For all other question from (2 to 11), The first part of each question carries one mark for each ‘YES’ option and no mark for ‘NO’ options. And the second and third part of each question carries one mark for each option.

Thus a total of 10×1=10 for first part of question

46×1=46 for second part question

38×1=38 for third part question

Total of 94 marks will be awarded under the knowledge regarding functional disability in aged and its supportive care among caregivers. It is interpreted in percentage as:

Adequate knowledge : Greater than 75%

Moderate knowledge : 50-75%

Inadequate knowledge : Less than 50%

VALIDITY OF THE TOOL

The tool used in this study was validated by the experts in the field of general medicine and Medical surgical nursing.

PILOT STUDY

The pilot study was conducted in Voluntary health service hospital, Dr.Kamakshi memorial hospital, Thoraipakkam and Navalur community area, Chennai from 20.7.12 to 25.7.12 after obtaining the permission from the respective heads of the organization.

Totally 6 caregivers (2 from each of the hospitals and community area) who fulfilled the inclusion criteria were selected purposively, to generalize the study. A

Understanding the Flow of Negotiations: Stages and Phases A. The typical steps or flow in a negotiation can be found in the phase models of negotiation: 1. Initiation. 2. Problem solving. 3. Resolution. Defines these three phases and give a

Understanding the Flow of Negotiations: Stages and Phases A. The typical steps or flow in a negotiation can be found in the phase models of negotiation: 1. Initiation. 2. Problem solving. 3. Resolution. Defines these three phases and give a

All nursing theories are developed in space and time, and are not value free. Select one nursing theorist and explain the factors that influenced development of the theory (history, scientific paradigm, and personal experiences–mentoring, education, practice.

All nursing theories are developed in space and time, and are not value free. Select one nursing theorist and explain the factors that influenced development of the theory (history, scientific paradigm, and personal experiences–mentoring, education, practice.

All nursing theories are developed in space and time, and are not value free. Select one nursing theorist and explain the factors that influenced development of the theory (history, scientific paradigm, and personal experiences–mentoring, education, practice, other). Provide reference(s) for your response.

Research article and a Case Study On Inflammatory Bowel Disease Custom Essay

Research article and a Case Study On Inflammatory Bowel Disease Custom Essay

You can interact with the rubric to grade in Grid View or List View. More Help
Content
Name: RESEARCH ARTICLE SUMMARY – I need this on the 9th of November(2 pages and please use 1 reference)
Description: PURPOSE OF PROJECT: Search various databases to find relevant and current research articles on pathophysiology. Read and analyze current literature and research related to course modules. . RELATED COURSE OBJECTIVE: Discuss current research in pathophysiology related to select patient case studies of pathophysiological processes across the lifespan.

? Grid View (active tab)
? List View
POINTS COMMENTS
1) 10 POINTS: Article is a recent publication (within 5 years) from a scientific, advanced practice, peer-reviewed journal that reflects a research focus Points:
10 (10%)

Feedback: Points:
0 (0%)

Feedback:
2) 25 POINTS: Summarize the major concepts and/or research question and research design covered in the research article. Points:
25 (25%)

Feedback: Points:
0 (0%)

Feedback:
3) 25 POINTS: Briefly describe the pathophysiology related to the problem or diagnosis being studied. Use your own words to describe the pathophysiology. Points:
25 (25%)

Feedback: Points:
0 (0%)

Feedback:
4) 25 POINTS: Analyze the article and findings of the research presented ? include the following:
1) Identify how did this article changed the way you thought about the subject; and
2) Identify specific actions or implications for your future practice, for society and/or the profession. Points:
25 (25%)

Feedback: Points:
0 (0%)

Feedback:
5) 10 POINTS: Use APA format for article summary and reference citation. Use correct spelling, grammar and sentence structure.
Use your own words, only one quote per page is allowable.
Use subheadings representing sections 2, 3, and 4.
Paper length: 1-2 pages (excluding title page and references). Points:
10 (10%)

Feedback: Points:
0 (0%)

Feedback:
6) 5 POINTS: Submit an electronic copy of the research article or URL address that can be accessed and viewed by the faculty. Points:
5 (5%)

Feedback: Points:
0 (0%)

Feedback:
Name:RESEARCH ARTICLE SUMMARY
Description:PURPOSE OF PROJECT: Search various databases to find relevant and current research articles on pathophysiology. Read and analyze current literature and research related to course modules. . RELATED COURSE OBJECTIVE: Discuss current research in pathophysiology related to select patient case studies of pathophysiological processes across the lifespan.

****** I WANT AN ELECTRONIC COPY OF THE RESEARCH ARTICLE USED****

Please focus on the research article summary first. Then use the research summary article as one of the references for the case study***

***INSTRUCTIONS FOR THE CASE STUDY** I have the case study which would be utilized in the case study part of the project****

Content
Name: CASE STUDY PAPER (6 pages and 9 sources including the research article summary. This should be referenced well and the research article summary should be included on the reference page.)
Description: PURPOSE: Select a disease of interest to examine the relationship between normal physiology and pathophysiology occurring in a case scenario. Analyze information from history, physical and diagnostic tests to support the diagnosis and discuss the pathophysiology of the case. RELATED COURSE OBJECTIVES: (1) APPLY KNOWLEDGE of physiological alterations and pathophysiological processes to disorders and diseases manifested across the lifespan. (2) DISCUSS current research in pathophysiology related to select patient case studies of pathophysiological processes across the lifespan. (3) DESCRIBE the relevant findings of diagnostic or other evaluative studies as they relate to pathophysiological processes. (4) APPLY KNOWLEDGE about pathophysiological processes to clinical reasoning in advanced practice nursing.

? Grid View (active tab)
? List View
POINTS COMMENTS
1) 5 POINTS – CASE STUDY SUMMARY: Develop a summary of a patient case scenario (in paragraph format) to include only pertinent: (a) Presenting signs / symptoms (HPI ? History of Presenting Illness) (b) Relevant History & Physical findings (c) Concluding diagnosis. Do not include normal findings, unless it is a pertinent negative finding. Points:
5 (5%)

Feedback: Points:
0 (0%)

Feedback:
2) 40 POINTS – PATHOPHYSIOLOGY of the DIAGNOSIS: Explain the pathophysiology of the problem or diagnosis and, as appropriate, contrast with normal physiology. Points:
40 (40%)

Feedback: Points:
0 (0%)

Feedback:
3) 30 POINTS – PATHOLOGICAL BASIS OF MANIFESTATIONS: Identify the manifestations presented in the case study that are relevant to the diagnosis and explain the underlying pathophysiology leading to each of the manifestations. Points:
30 (30%)

Feedback: Points:
0 (0%)

Feedback:
4) 10 POINTS – EVALUATION / DIAGNOSTIC STUDIES: Identify and discuss appropriate evaluation techniques or diagnostic studies that are specific to the case study. Discuss only those studies that are specific/sensitive to help differentiate it from similar pathology. Note: No discussion of treatment Points:
10 (10%)

Feedback: Points:
0 (0%)

Feedback:
5) 10 POINTS – REFERENCES: All references used are to be (a) advanced practice level (b) peer-reviewed (c) published within the past 5 years (unless historical) Cite at least two references used that are research-based Points:
10 (10%)

Feedback: Points:
0 (0%)

Feedback:
6) 5 POINTS – Use APA format for discussion and reference citation and (a) include an introduction and conclusion (b) use correct spelling, grammar, sentence structure (c) limit use of quotations to one per page (d) use section headings (e) follow HIPPA requirements (patient data is not identifiable) Points:
5 (5%)

Feedback: Points:
0 (0%)

Feedback:

CASE STUDY TO BE USED

Case:
CC: Bloody diarrhea and abdominal pain
HPI: The patient, a 25-year-old white male, was well and in his usual state of excellent health until 3 months ago when he had 3 to 4 days of bloody diarrhea. The diarrhea recurred approximately 4 times in the past 2 months; typically, it would last for several days, then resolve. The diarrhea was described as loose to semi-solid bowel movements occurring 4 to 5 times per day, and usually associated with mild cramps and left lower quadrant abdominal pain. With each bowel movement, there was a small amount of bright red blood. The blood was seen on the toilet tissue and mixed with dark yellow to brown stool. The most recent episode was more severe and lasted longer than usual (more than 6 days). The patient denies fever, night sweats, nausea, vomiting, abdominal bloating or distension, fecal urgency, joint pain, and rash. He denies unusual food exposures or recent travel. There have been no ill contacts. He reports that he has lost about 10 pounds unintentionally over the last 3 months.
PMH: occasional tension headaches
Medications: ibuprofen 400 mg prn headaches
FH: mother has Crohn?s disease.
SH: pt smokes about 1ppd
PE: only abdominal tenderness on palpation/percussion
Labs: Hgb 12.5, HCT 36, the rest unremarkable, stool cultures are negative, stool analysis is negative for ova and parasites
Pts’ physician has clinical suspicion that this patient has IBD.
Questions:
What additional tests will pt?s physician need to support this provisional diagnosis and to differentiate b/w Crohn?s Disease (CD) and Ulcerative Colitis (UC)?
What clinical and diagnostic features can help to differentiate b/w UC and CD?
What are the common complications of IBD?
What are the goals of therapy for IBD?
If this patient had UC, what are possible treatment options?
If this patient had CD, what are possible treatment options?
What else dose this patient need to know?
Answers:
What additional tests will pt?s physician need to support this provisional diagnosis and to differentiate b/w Crohn?s Disease (CD) and Ulcerative Colitis (UC)?
The two primary procedures used to confirm the diagnosis of IBD are colonoscopy/sigmoidoscopy (C/S) and barium contrast radiography. C/S, rather than contrast radiography, is better to define the severity and extent of mucosal inflammation. In addition, endoscopic biopsy can be done with C/S to permit a histologic diagnosis. C/S findings correlate better with disease activity and thus can be used to monitor response to therapy. Multiple biopsies may be necessary to differentiate UC and CD.
What clinical and diagnostic features can help to differentiate b/w UC and CD?
Ulcerative Colitis Crohn’s Disease
Circumferential disease Eccentric disease
Regional (continuous disease) Skip lesions (discontinuous disease)
Rectum usually involved Rectum normal in 50%
Confluent superficial ulcers Confluent deep ulcers
No aphthous ulcers Aphthous ulcers early
Collar button ulcers Transverse and longitudinal ulcers
Terminal ileum usually normal Terminal ileum usually diseased
No fistulas/strictures Fistulas/strictures are common
High risk of colon cancer Low risk of colon cancer
Risk of toxic megacolon No toxic megacolon
What are the common complications of IBD?
Some of the complications associated with CD include abscesses, fistulas, strictures, obstruction, perianal disease. These complications are usually not present in pts with UC. Extra-intestinal manifestations of IBD include arthritis, hepatic and biliary complications, urinary tract complications, dermatologic complications, ocular complications, amyloidosis, and hypercoagulability. Additional complications may result from malabsorption; they include anemia, cholelithiasis, nephrolithiasis, and metabolic bone disease. Extra-intestinal complications are usually less frequent with UC. The development of toxic megacolon, however, is more common in pts with UC than in pts with CD and may require emergency colectomy.
What are the goals of therapy for pt with IBD?
The goals of therapy are to induce remission of symptoms and mucosal inflammation and to maintain remission. Management depends on the clinical severity of the acute episode and on the anatomic extent of disease. It is also important to maintain an adequate nutritional status, minimize side effects of medical treatments, and improve pt?s quality of life.
If this patient had UC, what are possible treatment options?
For acute management of mild-to-moderate colitis, initial treatment options include oral aminosalicylates, topical aminosalicylates, or topical corticosteroids, depending on disease location. Remember that topical (rectally administered) agents only go as far as the splenic flexure. They do not affect the ascending or transverse colon. Treatment generally is efficacious within 2 to 4 weeks. The advantages of topical therapy are a more rapid response and less frequent dosing. 5-ASA therapy is effective in inducing and maintaining remission. Oral therapy with sulfasalazine is effective in inducing and maintaining remission; however, treatment with sulfasalazine may be limited by intolerance to side effects caused by the sulfapyridine component. Oral and rectal preparations containing 5-ASA (mesalamine) alone (e.g., Asacol, Colazal, Dipentum, Pentasa) may be useful in patients who are unable to tolerate sulfasalazine. Topical corticosteroid therapy is effective in inducing remission, but has not been shown to be effective in maintaining remission. Some patients, unresponsive to therapy given by one route, may respond to combination therapy with topical and oral therapies. In patients who are unresponsive to these therapies, oral corticosteroids are recommended.
Immunomodulators, such as 6-mercaptopurine (6-MP) and azathioprine, are used in UC for their steroid-sparing effect in patients dependent on corticosteroids. These agents should not be considered until a trial of 5-ASA maintenance therapy is tried first.
UC is cured by surgery! Surgery today doses not involve long-term presence of an ostomy.
If the patient had CD, what are possible treatment options?
For mild-to-moderate acute CD, treatment with oral budesonide or systemic (oral) corticosteroids is considered first-line therapy. For mild disease involving the colon alone, 5ASP may be useful. Antimicrobials can be added for (ileo) colonic or perianal disease (metronidazole or ciprofloxacin). For moderate-to-severe acute CD, oral corticosteroids are considered first-line therapy. Remember: you need to start your maintenance medication when you start corticosteroids. The addition of azathioprine or 6-MP to corticosteroids may also allow use of lower corticosteroid doses or even allow them to be tapered off completely. Methotrexate has also been used for this purpose.
Patients treated acutely with corticosteroids often relapse within one year without some maintenance therapy. Corticosteroids are ineffective for maintaining remissions in Crohn’s disease. Azathioprine and 6-MP are the drugs-of-choice for maintenance therapy in CD to prevent relapse after steroid-inductive therapy. Use methotrexate only if AZA/6-MP intolerant or pt. fails them. Infliximab (TNF antagonist) may be useful if oral maintenance therapies do not work optimally.
What else dose this patient need to know?
You need to tell him to avoid NSAIDs (i.e. ibuprofen). Even though NSAIDs are anti-inflammatory agents, they make IBD symptoms worse. Even COX-2 selective NSAIDs do this. He?ll need something else for his headaches (eg, acetaminophen).

To meet the needs of a changing healthcare system we need leaders who are innovative and can work together in teams to develop new ideas.

To meet the needs of a changing healthcare system we need leaders who are innovative and can work together in teams to develop new ideas.

Watch the three parts of The Deep Dive video. As you watch, record in your reflective journal what you think about what this team would look like if it were redesigning nursing education instead of a grocery cart.
• The Deep Dive – Part 1 of 3 [Video file][9 min 55 sec] • The Deep Dive – Part 2 of 3 [Video file][7 min 33 sec] • The Deep Dive – Part 3 of 3 [Video file][4 min 36 sec] Answer the following questions:
• Who would you want on the team?
• What would they do?
• Where would they go to get ideas?

Electronic Health Record and Its Implication on Anesthesia Practice

Electronic Health Record and Its Implication on Anesthesia Practice

The origins of the present electronic health record (EHR) systems date back as early as the 1960s. Teaching hospitals developed systems with hopes of creating a comprehensive patient database to manage and store patient health information; and shortly thereafter, the federal government instituted an EHR in the US Department of Veterans Affairs by the 1970s (Balestra, 2017). We are on the brink of a time of growing medical understanding, especially with a vast amount information to support healthcare decisions. Healthcare informatic concepts and tools are now part of the basis of biomedical science (Coorevits, et al., 2013). The development of health information technology (HIT) over the last 20 years have surely reformed the way health care is performed and how this information is being recorded. Currently, healthcare practice creates data exchanges and stores massive amounts of patient‐specific information in EHRs and ancillary databases (Coorevits, et al., 2013).

Hopefully, as key stakeholders develop healthcare policies and practice guidelines, they will use that to make a positive impact by integrating newer technologies into complex healthcare environments. In addition, the U.S. Health Information Technology for Economic and Clinical Health (HITECH) Act was adopted to promote electronic health records and related functionality (Cresswell, Bates, & Sheikh, 2013). However, it must have had to be determined if the existing technology could support these newer technologic goals.

Independent organizations are principally making these efforts. Research has shown that combining health records to create a more comprehensive health record is beneficial to healthcare organizations, providers, patients, and administrative staff. Some examples of these benefits include a reduction in costs, improved quality of care, the advancement of evidence-based medicine and record keeping and flexibility (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013).

Standards and Regulations

In February of 2009, the President signed into law the American Recovery and Reinvestment Act (ARRA). This act endorsed an almost 20-million-dollar investment to promote the use of EHRs in America. In addition, after the enactment of the ARRA, the HITECH Act was also put into action to further protect and promote the use of EHRs. The HITECH Act offered financial incentives to healthcare organizations that would implement an EHR system that would meet government standards. Subsequently, the Department of Health and Human Services (HHS) devised two regulations to encourage the use of EHR technology in the United States: 1) a notice of proposed rules for eligible providers, hospitals, and critical access hospitals to qualify for additional Medicare or Medicaid payments for the application and demonstration of Meaningful Use of EHR technology; and 2) developed a set of standards and certification criteria for EHR implementation (Galvez, et al., 2015). The EHR is a legal, computerized health record and therefore must be maintained according to state and federal standards (Balestra, 2017).

Legal and Ethical Issues

There are apparent, as well as hidden, legal responsibilities associated with EHRs. Providers should perform best practices when entering information, especially with remarks, addenda, and corrections after patient visits (Balestra, 2017). Some researchers suggest that audit logs and a de-identification method of patient’s health modifiers will reduce the incidence of ethical dilemmas. According to Fernández-Alemán, Carrión, Sr, Lozoya, & Toval (2013), each patient should have the ability to review their audit information and determine who has accessed their EHR, what information was retrieved, for how long, and for what purpose. Patients should also have information related to the creation of the record,

specific instances

of how the document is used, the process or processes by which the file is updated and eventually deleted (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013).

Significant ethical and legal consequences are associated with de-identification when using information for investigation (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). The process of de-identification involves changing identifiers from the personal health

data

so that proof of identity is not reasonably possible. This process is done to prevent the misuse of information. Ethical misuse could be in the form of denial of health insurance coverage. Other issues that may involve comprehensive EHRs that may lead to legal and ethical issues are copying and pasting of health record notes, the standardized use of work templates, late entries and changes, and incomplete documentation.

Healthcare providers are notorious for copying and pasting notes within the medical record in attempts to save time. Anesthesia providers may want to clone details from a previous exam, patient history, or event, but the information could be outdated or inaccurate (Balestra, 2017). An error like this would decrease the truthfulness of the medical record. In addition, if a provider mistakenly copied and pasted previous recorded vital signs and they are constantly repeated, that information could be used to bring about litigation for malpractice. Utilizing templates for specific health conditions can also produce legal issues. Templates that are very diagnosis specific or do not allow the input of newer information or test results for possible alternative conditions can open the provider to legal liability (Balestra, 2017). Another legality of the EHR are the alerts and triggered recommendations that come from the clinical support system. Bad habits can lead to disregarding these alert references from clinical support. Most comprehensive EHR systems record the time spent reviewing alerts and recommendations; and if that time is limited and something happens to a patient, the anesthesia provider could be held liable (Balestra, 2017). Late entries, failure to document, and incomplete or inaccurate documentation continue to cripple electronic medical records. The EHR is no different than handwritten healthcare notes in that “if it was not documented, it was not done.” It is difficult for anesthesia providers to document in the electronic record in real time due to the nature of the profession. It is negligent to pay more attention to the computer screen than the care of the patient in the operating room (OR). Consequently, revisions and changes to the EHR can occur; however, an ethical dilemma exists for this type of practice. Anesthesia providers have an ethical obligation to confirm that the record is completed on time as close to real time as possible. Documenting information after certain points in patient care or adding post-surgery addendums, corrections, retractions, deletions, or other late entries to the electronic record can expose anesthesia providers to liability and/or Board of Nursing issues (Balestra, 2017). Other issues that could present a problem are failure to electronically sign the chart or note, check marked boxes that lack supporting evidence that those services were performed such as auto-filled options. Failure to completely check the entire EHR for accuracy before sending the information into the record may jeopardize how truthful the patient or other providers believe that the information in the health record is (Balestra, 2017).


Patient Safety.

EHRs can present patient safety concerns. Anesthesia providers must remain diligent and take precautionary measures to protect themselves and assure their patient’s safety. A positive step towards this endeavor comes in the form of EHR training classes offered by the organization. These types of courses are important because they confirm that specific criteria are met and that the operators can use the system as it was planned. Although it may seem futile, lack of eye contact can cause an issue with patient safety. Imagine when a provider stares at the computer screen as they attempt to input information into the EHR in real time with the patient behind their back. Patients often feel disregarded and this creates a communication block, potentially interfering with discussions about the patient’s current health status, recent test results, or any medications the patient is taking (Balestra, 2017). Medication safety is a primary patient safety concern, as the categories of prescribing, transcribing, dispensing, and administering can be disorganized, leading to EHR-associated medication administration errors (Balestra, 2017). As I stated earlier, templates can create a problem due to the automatic nature of how it documents into the medical record. Clinical decision-making is based on real-time information, so other patient care issues can occur when anesthesia providers have access to incomplete information when dealing with a patient; for instance, the workstation is offline and no back-up is available or patient medical data (Balestra, 2017). By integrating these recommendations into their practices, anesthesia providers can help ensure quality patient care, patient safety, and increased efficiency.


Security and Privacy.

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) offers data privacy and security requirements for safeguarding medical information (Balestra, 2017). The security management procedure standard is a requirement in the HIPAA Security Rule, and HIPAA privacy and security requirements are rooted in the Medicare and Medicaid Electronic Health Record Incentive Programs through the meaningful use requirement (Balestra, 2017). Violating privacy when using the EHR will result in hefty fines of HIPAA. All healthcare providers are focused on preventing unauthorized access to patient information, including threats from poor password management, disgruntled or disloyal coworkers, and external threats, such as theft of electronic devices containing health information (Balestra, 2017). Policy development has made little progress for the changing of some privacy issues relating to movement from a paper-based health record system to one that is integrated and electronic (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). Even with improvements in cyber security, it is difficult to stay ahead of hackers. With each progression in technology, increased threats to the patient’s EHR and privacy have led to situations in which their health information is confronted by newer security and

privacy threats

(Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013).

There are three key safety goals that are used to promote EHR security, these being confidentiality, integrity, and availability (CIA). Confidentiality is that the protection and security of

personal information

is critical in the healthcare arena; therefore, it is necessary to guarantee the CIA of all

personal health information

(Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). The integrity of health information must be protected to safeguard patient safety. An important element of this protection is the guaranteeing that the information’s entire life cycle is completely inspected; while availability refers to the nature of being available and practical when needed by an authorized entity (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). Health informatics systems must remain functioning in the face of natural disasters, and system failures. Security also involves accountability, which refers to people’s right to criticize or ask why something has occurred (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). There have been many threats with regards to security and privacy of EHRs, such as hackers, viruses, and internet worms. It is extremely important to know and understand how these dangers affect the EHR so that proper measures can be instituted to protect the data. Failure to maintain data security and privacy is becoming a global epidemic.

According to Fernández-Alemán, Carrión, Sr, Lozoya, & Toval (2013), a recent study estimated that there are almost 25 million forced authorizations for the disclosure of health records in the United States (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). Anesthesia providers must take precautionary measures in ensure that provider access to health records is on a need to know basis only.

Allowing patients to access their own healthcare records is a step towards improving the healthcare system and promotes ownership of their well-being. However, this opens new security threats. There could be various levels of access within an EHR. A patient’s EHR might be divided and available from several locations, such as when patients visit different doctors’ offices, hospitals, and other providers (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). Flaws in this type of security could cause the release of information to

unauthorized persons

or companies; therefore, extra precaution should be taken to protect medical information from manipulations or unauthorized accesses (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). This also includes access by administrative staff. EHRs could have issues with privacy because staff with higher level access may gain access to patient information without their consent (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). To assure that this rarely occurs, most organizations require the input of a user authentication process be enforced.

User verification

can be defined as the way in which users prove their validity to the EHR by submitting their username or identity (ID) with an associated password (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). Another type of user validation is data authentication. Data authentication is the process used to ensure the origin of a data source, which is usually done by a

digital signature scheme

. (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). Caution must be taken with these since it is possible to have your user ID and password information stolen. The use of passwords as a means of authentication predisposes the EHR to many types of attacks. For instance, using passwords as a way of authentication exposes the record to “electronic monitoring or unauthorized access to the password file ” (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). More intense security features involve using a

two-factor authentication

process. According to Fernández-Alemán, Carrión, Sr, Lozoya, & Toval (2013), there are three specific ways to maintain a proper security ID system, with at least two of them to endorse the implementation: “something a person knows” (login ID, email address, password, PIN); “something a person has” (key, swipe card, access card,

digital certificate

); or “something that identifies a person” (face and voice pattern identification, retinal

pattern analysis

, hand characteristics or automated

fingerprint

analysis based on pattern recognition). Newer technology has focused on a radiofrequency-type ID badge. Using a badge with an embedded radiofrequency ID chip might be considered invasive to some experts; however, it could also be beneficial for securing health information (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). This type of badge would hold users accountable for their actions within an EHR.


Workflow Processes – Benefits and Implications.

The workflow processes of a comprehensive EHR are both rewarding and challenging. Anesthesia providers deliver care founded on evidenced-based practice. Anesthesia care workflow processes must be supported by the EHR to incorporate these best care practice. In other words, EHRs should possess continuous workflows that display the correct tools, have evidence-based content, and trigger information at the right time for optimal clinical decision making (O’Brien, Weaver, Settergren, Hook, & Ivory, 2015). The manner in which anesthesia providers are able to document in the EHR should capture their impact on the entire interaction between patient and provider. This is a means to demonstrate the safe, efficient, and reliable patient care that nurse anesthetists have been proven to deliver. Nowadays, most health care organizations receive compensation for services based on patient outcomes following care. The documentation provided by nurse anesthetists in the EHR can show the degree of quality of care delivered not only in the perioperative process but any area of the healthcare organization requiring anesthesia services. According to a study by Jang, Yu, Kim, Moon, & Kim (2013), electronic anesthesia records were found to be more complete than that of manual, paper records, perhaps due to the automatic transferring of data and reuse of information from the EHR.

The EHR is not without its liabilities. Advancements in technology can be annoying for providers who are the primary users of the EHR because the updates and revisions may not fit their usual workflows (Cresswell, Bates, & Sheikh, 2013). For example, nurse anesthetists will have different documentation requirements than those of anesthesiologists. Regardless of the desires or requests of the users, the ultimate focus is to provide the highest quality of care. Extensive training on the EHR is fundamental to achieve stakeholder buy-in. Training is often specific to the user; however, caution must be exercised that the user understands the entire function of the EHR. In training, users gain the most retention of information when it involves simulation of their actual role simulate the actual working environment as possible (Cresswell, Bates, & Sheikh, 2013).

Another issue in the workflow process involves emergencies. Standard policies are overlooked in the face of emergencies. When this occurs, specific job roles must be reviewed, and their actions must be entirely justified. However, some accesses should always be prevented because they cannot help in dealing with emergencies and could signify mishandling of patient information (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013). Furthermore, reviews or audit-logs are an essential part of the workflow process. Audit logs can identify if a patient’s EHR has been compromised. Reviewing user access of patient files is imperative for safety and security, and it is critical that the policies put in place to protect patient privacy are enforced (Fernández-Alemán, Carrión, Sr, Lozoya, & Toval, 2013).

It is difficult to sense EHR-related safety concerns, as well as prevent them because the issues can be extremely complex. EHR-related safety concerns are challenging because they are often complex, involving the potentially unsafe functions of the EHR as well as user behaviors, organizational characteristics, and rules and regulations that control EHR-related activities (Meeks, et al., 2014). Nurse anesthetists must remain vigilant in their documentation practices and protection of patient information within the EHR. It can be expected that with the extensive economic and healthcare organization investments made into the implementation of EHRs nationwide, electronic prescribing, telehealth, and related technologies will modernize healthcare work processes and improve the value, security, and proficiency of care delivered (Cresswell, Bates, & Sheikh, 2013).

Conclusion.

Electronic health information systems have become a permanent component in health care (Balestra, 2017). While it has improved overall health care and increased provider accountability, more work needs to be done to guarantee the best in security, privacy, safety, and efficiency. Nurse anesthetists continue to balance patient care with data entry requirements. Meanwhile, most are aware that information technology is vital for improving the quality of care; therefore, they are devoted to working with these systems to improve user functionality (Balestra, 2017). Having a mature EHR system obviously does not eliminate the EHR-related safety concerns (Meeks, et al., 2014). All providers must continually assess the integrity of the EHR to prepare for future updates and submit their user suggestions, especially after the ‘go live’ process has occurred.

References

  • Balestra, M. L. (2017). Electronic Health Records: Patient Care and Ethical and Legal Implications for Nurse Practitioners.

    Journal of Nurse Practitioners, 13

    (2), 105-111. doi:10.1016/j.nurpra.2016.09.010
  • Coorevits, P., Sundgren, M., Klein, G. O., Bahr, A., Claerhout, B., Daniel, C., . . . Kalra, D. (2013). Electronic health records: new opportunities for clinical research.

    Journal of Internal Medicine, 274

    (6), 547-560. doi:10.1111/joim.12119
  • Cresswell, K. M., Bates, D. W., & Sheikh, A. (2013). Ten key considerations for the successful implementation and adoption of large-scale health information technology.

    Journal of the American Medical Informatics Association, 20

    (e1), e9-e13. doi:10.1136/amiajnl-2013-001684
  • Fernández-Alemán, J. L., Carrión, Sr, I., Lozoya, P. Á., & Toval, A. (2013). Security and privacy in electronic health records: A systematic literature review.

    Journal of Biomedical Informatics, 46

    (3), 541-562. doi:10.1016/j.jbi.2012.12.003
  • Galvez, J. A., Rothman, B. S., Doyle, C. A., Morgan, S., Simpao, A. F., & Rehman, M. A. (2015, September). A Narrative Review of Meaningful Use and Anesthesia Information Management Systems.

    International Anesthesia Research Society, 121

    (3), 693-706. doi:10.1213/ANE.0000000000000881
  • Jang, J., Yu, S. H., Kim, C.-B., Moon, Y., & Kim, S. (2013). The effects of an electronic medical record on the completeness of documentation in the anesthesia record.

    International Journal of Medical Informatics, 82

    (8), 702-707. doi:10.1016/j.ijmedinf.2013.04.004
  • O’Brien, A., Weaver, C., Settergren, T., Hook, M. L., & Ivory, C. H. (2015). EHR Documentation: The Hype and the Hope for Improving Nursing Satisfaction and Quality Outcomes.

    Nursing Administration Quarterly, 39

    (4), 333-339. doi:10.1097/NAQ.0000000000000132

What roles do leadership and physicians play in an HCO’s clinical quality improvement program?

What roles do leadership and physicians play in an HCO’s clinical quality improvement program?

Clinical quality is an extremely sensitive subject; implying stakeholders in healthcare organizations have the responsibility of approaching the matter with high levels of insight and focus. Physicians and leaders play distinctive roles need to guarantee high degrees of clinical quality. First, physicians and leaders must guarantee that clinical care is primarily patient-centred. As a result, administrative and political leaders ought to make sure that medical personnel put the needs of patients first (Marquis & Huston, 2008). It is a conventional practice for private practitioners to focus more on profitability than offering quality medical care. Besides poor quality medical care, patients are extremely overcharged; therefore, leaders must make sure that there are effective rules outlining the provision of exceptional services that prioritize patients’ interests.

Physicians are suitably positioned to enhance the quality of clinical care. For instance, they offer first-hand and updated information regarding the quality of clinical care. Physicians have direct contact with patients, implying that they have the capability of formulating current trends in medical care, which is helpful in decision-making (Rigolosi, 2005).

Leadership also plays a key part in the distribution of resources needed to advance clinical care. Leaders have the responsibility of prioritizing critical issues in medical care beginning with the most pressing issues like responding to disease outbreaks. Physicians can also improve clinical quality using extensive research. Physicians can perform medical studies in the laboratory and gather relevant data, which is vital in the planning and formulation of clinical improvement initiatives. Physicians can also initiate follow up measures to evaluate the effectiveness of the current medical care. In the light of this view, decision makers can devise methods to enhance existing strategies or formulate new processes (Van Wart, 2007).

Leadership influences the distribution of resources required for the improvement of clinical care. With this respect, leadership must guarantee the allocation of funds in accordance to priority. For instance, areas with higher population density require more resources than areas with low population density irrespective of the socio-economic conditions (Van Wart, 2007). In addition, leadership plays a crucial role in mobilizing resources for clinical improvement programs. Leaders have the responsibility of searching for grants and donations from governments, corporations, nongovernment organizations, and individuals. Leaders also kick start financial programs to aid healthcare organizations accumulate their own resources needed to support and improve the quality of clinical care.

References

Marquis, B., & Huston, C. (2008). Leadership roles and management functions in nursing:. New York, NY: Lippincott Williams & Wilkins.

Rigolosi, E. (2005). Management and leadership in nursing and health care: An experiential approach. New York, NY: Springer Publishing Company.

Van Wart, M. (2007). Leadership in public organizations: an introduction. New York, NY: M.E. Sharpe.

Health Profile of Enfield: Focus on Strokes


Contents


Introduction…………………………………………….1


Demographic Profile of Enfield…………………………………1

-2


Health Issue in Enfield……………………………………..2


Who is affected? Health Inequalities …………………………….2

-3


Social Determinants of health


Policy issues relating to Stroke……………………………….4-5


Public Health Provisions in Enfield…………………………….5-7


Conclusion……………………………………………..7


Reference List………………………………………….7-8


Introduction

This report will be divided into three sections.  In section 1, I will be talking about the profile of the London borough of Enfield, health issue (Stroke as an issue), the social determinants of health and the relationship to health inequalities.  Section 2 will cover a relevant stroke policy on the national level and what it suggests and what it does not address.  In section 3, I will identify a relevant Public Health Provisions and how they address the health inequality in the borough. I will also talk about the gaps that I identified in health provision in the borough of Enfield.


Demographic Profile of Enfield

The borough had a population of 324,500 in 2014 with a large proportion of the population being 0-14s and older generation compared to the rest of London. Enfield is very diverse as it has communities from all over the world (Enfield Council, 2019).

Based on the 2017 Enfield Ethnicity estimates, residents from White British backgrounds make up 34.77% of Enfield’s inhabitants with other White groups at 25.23%, Other Ethnic Groups at 6.14%, Mixed Groups at 5.34%, Asian Groups at 10.24% and Black groups at 18.28% (Enfield Council, 2018).

Enfield is ranked as the 64

th

most deprived out of 326 local authorities in England.  Deprivation is correlated with worse health, high morbidity and high mortality.  The largest cause of death in Enfield is Cardiovascular Disease (stroke, coronary heart disease and heart failure) followed by cancer. (Enfield Council, 2014)

In the borough of Enfield, according to rank, the deprived wards are, Edmonton Green, Upper Edmonton, Lower Edmonton, Ponders End and Turkey Street.  The three Edmonton wards are within the most deprived 10% of wards in England.  Out of the borough’s 21 wards, twelve are among the most deprived 25% of wards in England (Enfield Council, 2019)


Health Issue

The health issue that I will be highlighting in this report is Stroke as deaths from circulatory diseases which includes ischaemic heart disease and strokes accounted for 32% of deaths in Enfield borough.  Stroke occurs when there is no supply of blood to the brain and it can lead to brain cell damage or death.  Strokes can occur as a result of blockages in arteries that give oxygen-rich blood to the brain (ischaemic strokes) or it can be caused when there is bleeding in the brain refers to as haemorrhagic strokes. There is also another type of stroke known as transient ischaemic attacks(TIA’s) which is a mini stroke caused by a temporary blockage of the artery (Enfield Council, 2017).


Who is affected? Health Inequalities

Health inequalities is a term used to explain the disparity in health status among and within people with similar social and economic status (Wistow, 2015).

The Marmot review came out on 11 February 2010 to address the issue of health inequalities in England.  The report was based on addressing the social determinants of health.  It states that people’s environment, work and age result to health inequalities.  The report shows that housing, income, education, social isolation and disability have a have a negative effect on people’s health.  It states that if someone’s social economic status is low, the person/s health is likely to be poor (Local Government Association, 2019).

Health inequalities can be tackled by a joint action across all the social determinants of health by closely looking at education, occupation, income, home and community.  The report suggests that to reduce health inequalities there should be a joint action looking at the population health status and related inequalities in social status (Local Government Association, 2019).

In Enfield, circulatory diseases which includes stroke are the biggest causes of life expectancy gap that accounts for 26% of the male life expectancy gap and 29% of the female life expectancy gap.  Those that are at highest risk of stroke in Enfield are older people (mostly over 65), people who live in Edmonton Green Ward, those of African and Caribbean ethnicity and those who have a family history of stroke or TIA  (Enfield Council, 2011)



People need good income to access the resources that are needed for good health and well-being.  In Enfield almost 35% of children were estimated to be living in poverty in 2009 and the income level in Enfield is low compared to other parts of London.  The borough has the 7

th

highest percentage of children who live in workless households across the London boroughs (Enfield Council, 2012).




Social Determinants of health




(200 words)




Social Determinants of health are interfering factors that affect people’s health status.  These are conditions such as where people are born, grow, live, work and age and they are influenced by how money, power, resources at global, national and local levels are distributed.  The social determinants of health is the reason for health inequalities around the world and also contributes to the unfair and differences in health status (W.H.O, 2019).



From April 2012 till March 2013 the employment rate in Enfield stands at 67%.  This figure is the eleventh lowest in London and it is below the London average of 69.5% and the England average of 71.1%.  The rate of those people who are economically active in Enfield was 74.7% which is the 10th lowest rate in London.  This is a little below the London average of 76.4% and the England average of 77.3% (Enfield Council 2014).

The residents of Enfield experience greater levels of deprivation when compared to London as a whole.  29% of Enfield children live in household of worklessness which is the 7th highest among the London boroughs.  Those adults who are of working age and who claim out of work benefits make the borough the 10th highest across the London boroughs (Enfield Council, 2012).




Policy issues relating to stroke (500 words)



Health policy approach alludes to the collection of plans, laws, controls, choices, methods, practices and activities that are embraced by a society to improve the well-being of the people who live in that society.  A large perspective of it is to do with improving the physical health of its inhabitants, for example giving people easy access to its public health clinics.  However, some parts of health policy may not be directly linked to health (Ungvarsky, 2019).

In January 2019, NHS England made known its Long Term Plan, in which stroke has been named as a new national priority.  It plans working with partners in order to improve stroke care from the onset of stroke to ongoing care.  This plan incorporates avoidance, treatment and rehabilitation (NHS England, 2019).

The National Stroke Program has been created in agreement with the NHS England and the Stroke Association in discussion with clinical specialists and individuals that are affected by stroke. The programme will work in collaboration with local organisations on the best ways to prevent, treat and care for those 80,000 who have stroke in England each year and meet the desire for stroke as set out within the long term arrangement (NHS England, 2019).

The programme purposes to improve post-hospital stroke recovery models for stroke survivors.  It plans to deliver a ten-fold increment within the context of patients who get a thrombectomy after stroke each year so as to enable 1,600 more individuals to be independent after their stroke.  It also aims to train more clinic specialists to give mechanical thrombectomy and double the number of patients who receive clot-busting thrombolysis (Guaranteeing 20% of those who suffer from stroke get it by 2025).  The plan also aims to enhance the Sentinel Stroke National Audit Programme (SSNAP) to recognise further need and drive improvements.  The plan also aims to ensure that three times as many patients receive 6 month reviews of their recuperation and needs from the current 29% to 90% (NHS England, 2019).

According to the King’s Fund the national leaders should be giving credit for focusing on quantifiable improvements in health outcomes.  Their commitments will spare lives make the lives of patients feel better.  But there is a big question as to whether the plans can be delivered as the government has to increase staff, especially in the primary care.  They should also need to invest in diagnostic equipment and leaders on the national level. The plan is committed to patients’ involvement in their own care but it does not talk about patient and public involvement in shaping health services and it has left out the role of communities in health care (The King’s Fund, 2019)

The Sentinel Stroke National Audit Programme (SSNAP) says the method to use thrombectomy has appeared in trials to see greater results in patients who qualified once it is performed within few hours of stroke.  But, the required facilities for thrombectomy are accessible in a little number of centres and there is a deficiency of qualified staff to perform the procedure (NICE, 2019).

The aforementioned health policy has not addressed people’s income in Enfield borough and it’s main focus is the health issue directly.  However, it has given access to services for those who suffer stroke.




Public Health Provisions in Enfield borough

Public health is the science and craftmanship of avoiding illness and ensuring that people’s lives are prolonged.  It is about the joined efforts of the informed decisions of society as a whole including the public and private sectors, communities and individuals working together to promote well being (Winslow 1920 cited by Viseltear 1982).

Winslow acknowledges that it is not only the medical discoveries that contribute to how we feel but our social relationships, the environment where we dwell and our sense of purpose in life are some of the factors he looked at to be the arts of public health (Thompson, 2014).

Enfield at this present time does not have a dedicated stroke rehabilitation team with little access to generic rehabilitation.  However, it has two services for patients that require rehabilitation.  One is Generic community rehabilitation service that is run by Enfield Community Services and the second one is Out-patient rehabilitation provided by Barnet and Chase Farm Outreach team. These services are able to provide short term intervention following patients’ discharge from hospital.  There is little provision for community rehabilitation and this is identified as a gap in Enfield Council.  The services provide interventions in the area of assessments, education, clinical managements, home visiting services for household patients, limited neuro-physiotherapy service, limited adult speech and language support, assessment and provision of walking aids and simple communication aids plus telephone reviews and support (Enfield Council, 2011).

The stroke outreach provides limited therapy service to patients who have suffered a stroke post discharge. In 2009 to 2010, 101 referrals were made to the service and 67 that met the criteria of the outreach were accepted (Enfield Council, 2011).

Enfield provides support in the area of community re-integration and includes support for their relatives, carers so as to gain back a good quality of life and be able to live independently (Enfield Council, 2011).

Stroke survivors can have access to homecare, residential care and day care.  Enfield provides psychological therapies for those who have mild to moderate needs and those individuals who have severe and prolonged mental health problems (Enfield Council, 2011).

In addition, The Voluntary and Community sector in Enfield provide a wide range of services that support people to maintain their independence and wellbeing (Enfield Council, 2011).

Also, they provide support for people who are unable to live in their homes because of stroke.  They provide residential and nursing care placements at a cost to the Council.  This is addressing the social determinants of health as the income level in Enfield is low in comparison to other parts of London (Enfield Council, 2011).

Total Healthcare and Stroke Action provide services named Social Stroke Support to 35 stroke survivors and their carers to avoid social exclusion (Enfield Council, 2011).

Enfield Council has addressed social determinant of Health by providing residential support for those who need it at a cost to the council.  In addition to the provision of walking aids and simple communication aids to those who suffer from strokes.




Conclusion

In this report, I have looked at the profile of Enfield borough and highlighting stroke as an issue.  I have also talked about the social determinants of health and its relationship to health inequalities.  I have also looked at relevant stroke policy on the national level.  I have also talked about a relevant Public Health Provisions in the borough, looking at whether or not it has addressed the issue of health inequality in the borough of Enfield.

In the light of all that I have discussed above, I believe that the government has a long way to go in addressing health inequalities in our society and until they start addressing the social determinants of health, the disparity in health care would continue to widen.




Reference List

Motivation interviewing: Smoking cessation

Despite the smoking ban making it illegal to smoke in enclosed public places, introduced in England in 2007, smoking remains one of the single greatest causes of preventable illness and premature death in the UK. (1) There has been a reduction in rates of smoking, but a challenge remains in targeting high risk, hard to reach groups such as pregnant women.

Smoking during pregnancy, or even passive smoking, can cause serious damage to the health of both mother and baby. (21, 3) Indeed, smoking in pregnancy is one of the main causes of premature births and miscarriages. It has been shown that women who smoke during pregnancy have 1.5 to 3.5 times more chance of miscarriage when compared to non-smoking women. (4) Some women continue to smoke due to evidence that smokers have smaller babies. However, this is due to a lack of oxygen, which can severely affect the baby’s growth and development as well as cause numerous health problems in the future.

The implications of smoking during pregnancy go beyond affecting the mother and her baby, creating additional burden to an already overstretched national health service (NHS). It has been estimated that the increased cost to the NHS of smoking during pregnancy is £1,500 per smoker. (5) Thus, it has been recommended by the NHS Centre for reviews and dissemination that pregnant women are offered intensive advice and support to stop smoking. They specify that a combination of prenatal counselling, 10-minute face-to-face contact, and the provision of tailored written material, can double quit rates to about 15%. (6) Furthermore, a systematic review of best evidence, as conducted by the Cochrane Collaboration, indicates that the benefits of smoking cessation programs for pregnant women are great enough to recommend that they become routine within antenatal practice. (7)

The need for routine antenatal smoking cessation programmes is unquestionable. Research conducted by the British Market Research Bureau (BMRB) in 2005 demonstrated that 32% of mothers in England smoked during the 12-months before pregnancy and continued to smoke during pregnancy. (8) Although nearly half (49%) quit smoking before giving birth, three out of ten (30%) started smoking again less than a year after giving birth. It has been proposed that this is because women are usually motivated to stop smoking for the sake of the baby rather than for personal, long-term health reasons. Therefore, not only is there concern for the one in six (17%) women who continued to smoke throughout their pregnancy, there is also a need to promote long-term abstinence within public health initiatives. Of note, rates of quitting are generally lower among heavy smokers who are unmarried, on a low income, and poorly educated. (9) Therefore, meeting this public health challenge is likely to require highly targeted strategies in order to reach some of the most at risk groups of pregnant women.

Helping pregnant women to stop smoking is notoriously difficult due to the stigma attached to smoking while pregnant. The associated shame experienced by many women acts as a barrier to seeking help, as well as openly discussing smoking habits when questioned. This places pregnant women and their babies at increased vulnerability of complications resulting from continuing to smoke. It also increases the pressure on healthcare professionals to communicate the importance of smoking cessation to pregnant women, which can increase workload and also damage the relationship between pregnant women and their healthcare providers. Healthcare professionals are, understandably, keen to encourage pregnant women to stop smoking due to the known dangers; yet this can add to the shame experienced by the pregnant woman as well as be interpreted as confrontational, thus making them defensive.

There is a clear need for a public health intervention targeted not only at pregnant women, but also at their healthcare providers. The healthcare professional is key to educating pregnant women about the impact of smoking on themselves and their baby. Furthermore, it has been found that self-management initiatives related to health behaviours are unlikely to be sustained without the support and endorsement of health professionals. (10) However, there appears to be a skills gap that needs to be addressed in order for healthcare professionals to be able to approach this sensitive topic in a way that empowers the pregnant woman.

The challenges posed by pregnant women who continue to smoke require the establishment of an evidence-based programme of care that is integrated into the routine care delivered throughout their pregnancy. It is proposed that such an initiative would comprise an advanced development programme for the training of healthcare professionals in behaviour change techniques and, more specifically, in motivational interviewing skills. These skills are becoming more popular within the healthcare setting as they provide a brief psychotherapeutic communication style aimed at increasing the likelihood that a person will attempt to change unhealthy behaviours such as, in this case, smoking.

Motivational interviewing is a patient-centred style of communication designed to help people resolve any ambivalence they might have about changing an unhealthy behaviour, thus recognising that even unhealthy behaviours offer perceived benefits to the person carrying them out. It attempts to guide people towards personally choosing to change their unhealthy behaviour, rather than imposing expectations of change upon them, something which is frequently experienced by pregnant women who smoke. (11) This technique is based on the premise that if a person chooses to stop smoking themselves, they are more likely to be successful at any attempts to quit smoking.

The motivational interviewing technique is based on the transtheoretical model of behaviour change. (12) According to this theory, to achieve permanent change people go through a process of five distinct stages: pre-contemplation (i.e. not yet acknowledging an unhealthy behaviour that needs to be changed); contemplation (i.e. acknowledging the unhealthy behaviour, but not yet sure whether one is ready or wants to change); preparation (i.e. getting ready to change, perhaps setting a quit date); action (changing the unhealthy behaviour); and maintenance (i.e. remaining abstinent). In this sense, motivation is something that gradually grows and thus can be assisted by health professionals who are well placed to assess motivation to change. (13) Furthermore, with continued support, relapse prevention strategies can lower the likelihood of women returning to smoking which, as mentioned earlier, does frequently occur when smoking cessation is not motivated by personal reasons.

This model illustrates that approaching the issue of smoking during, for example, a stage where the woman has no intention or desire to change might become a confrontational consultation. However, motivational interviewing can be used to empower pregnant women in a way that encourages progression through the stages of change process. Motivational interviewing techniques that can assist with this include utilising open questions that convey the message that there are no preconceived views or judgments being made about the pregnant woman and her smoking habits. Closed questions, on the other hand, are often leading and thwart with expectation. With motivational interviewing, the primary goal is for the pregnant woman to be an active participant in the conversation and not just a passive recipient of information.

The four core principles to motivational interviewing are: expressing empathy (i.e. reflecting on and expressing an understanding of the pregnant woman’s perspective); developing discrepancy (i.e. exploring discrepancies between attitudes and beliefs and actual behaviour, e.g. believing smoking is unhealthy but continuing to smoke); rolling with resistance (i.e. understanding the barriers to change experienced by the pregnant woman, as well as any resistance to change); and supporting self-efficacy (i.e. working towards increasing the pregnant woman’s confidence in her ability to quit smoking and cope with any setbacks). (14)

These four core principles can be taught to health professionals to enhance their communication skills within health promotion initiatives such as one that targets pregnant women who smoke. Such skills are most often utilised in face-to-face consultations, but can also be used over the telephone; they are not intended for use within group settings. The application of motivational interviewing skills is diverse and yet can be taught to all health professionals over a period of 2-12 hours, usually via workshops. (15, 16)

The training does not have to be overly intensive and once this skill is adopted it can be delivered merely via conversation during regular consultations with the patient. A recommended programme would be to provide healthcare professionals who work with pregnant women with a 2-day training programme and to monitor the integration of these skills into practice. The advanced communication skills gained from the training, after practice, can become second nature and part of everyday practice. Indeed, motivational interviewing skills are transferrable to everyday face-to-face or telephone consultations. (17) Not only will these skills assist pregnant women in changing their behaviour, but they are also likely to prevent confrontations associated with the sensitive issues being addressed.

Evidence for the efficacy of motivational interviewing in helping pregnant women to stop smoking is strong. The most frequently adopted approach has been one in which smokers are provided with feedback, in a non-confrontational manner, intended to develop a discrepancy between their smoking behaviour and their personal goals. (18) Such a discrepancy is likely to lead to the uptake of any support that is offered to the pregnant woman as she commences attempts to quit smoking.

Karatay, Kublay and Emiroglu (2010) examined the effect of motivational interviewing on pregnant women (n=38) taking part in a smoking cessation intervention based on the transtheoretical model. (19) They found that 39.5% of the women were able to give up smoking, whilst 44.7% were able to reduce their rate of smoking by 60%. Rates of passive smoking pre-intervention, which were 86.8%, decreased to 55.3% post-intervention. Interestingly, mean self-efficacy scores increased substantially from 61.36 pre-intervention to 93.34 after the intervention. Not only had the motivational interviewing facilitated smoking cessation in some of the women, but it also reduced passive smoking and increased confidence in one’s ability to stop smoking and remain abstinent.

The important components of this intervention were reported to be the provision of information designed to raise awareness of the dangers of smoking, helping the woman identify and understand her reasons for smoking via a thoughts and feelings diary, and motivating the woman to consider any ambivalence she might have about quitting smoking. Other important components included helping the woman prepare herself for any quitting attempts by facilitating a decision regarding the method and date for quitting and putting in place methods to prevent passive smoking. It was also fundamental that sources of support were identified for helping the pregnant woman overcome any problems associated with giving up smoking so that she can succeed with her goal of being smoke-free.

In another study, where women (n=302) were randomly assigned to receive motivational interviewing or usual care, motivational interviewing was found to be relatively cost-effective. (20) The intervention comprised education about the impact of smoking on themselves and their baby, being helped to evaluate their smoking behaviour, and being taught skills that would increase their self-efficacy for smoking cessation and abstinence. The women were also provided with information on how to reduce passive smoking, as well as supported to set goals that would facilitate smoking cessation. At 6-months postpartum, for smoking cessation, motivational interviewing cost more for no additional benefit when compared to usual care. The motivational intervention did, however, prevent relapse more effectively than usual care, which in turn increased the cost-effectiveness of the initiative.

Some studies have reported low efficacy for using motivational interviewing with pregnant women who continue to smoke, but the majority of the evidence is in favour of the technique. (21) Even in the aforementioned study reporting low efficacy, fewer women in the motivational interviewing intervention reported that they were smoking more, when compared to the control group.

In order to deliver a training programme for health professionals involved in the care of pregnant women, organisational change will be necessary in order for new ways of working to be integrated into everyday practice. This will require the support of organisation Managers as well as commissioners who might fund a pilot study to test the effectiveness of training staff in motivational interviewing skills. In addition, input from the NHS, especially NHS Stop Smoking services, is likely to enhance the long-term effectiveness of such initiatives by acting as a resource for professionals to refer pregnant women for follow-up support.

The first step in the delivery of the initiative would be designing and conducting the initial training, which will be designed to develop communication skills in motivational interviewing during consultations. Importantly, however, according to a systematic review conducted by Soderlund et al. (2010), follow-up training or ‘refresher’ sessions might be necessary at appropriate intervals and this will need to be considered in terms of resource allocation. (22)

Velasquez et al. (2000) describe the process of training healthcare providers to use motivational interviewing with pregnant women, demonstrating that public health nurses and social workers are generally enthusiastic about attending training workshops and rate them as effective in preparing them to utilise motivational interviewing skills in practice. (23)

Hassel and von Rahden (2007), as part of a larger project, developed a 2-day programme of training in motivational interviewing for midwives. (24) The programme was designed around the stages of change model and focused on counselling skills that could be used to facilitate transition through the stages. This has also been referred to as ‘change talk’. (25) For example, techniques like the ‘Importance Ruler’ (used to assess how important smoking cessation or her baby’s health is to pregnant woman) were taught as a tool for progressing a conversation to the contemplation stage. It was found that this training provided the midwives with a greater array of practical tools they could use in their daily work. The skills that motivational interviewing practitioners need are those that are needed for enabling communication in all areas of healthcare: reflection, active listening and open-ended questioning. Therefore, the training is beneficial across all work the healthcare professional might be involved in.

Although motivational interviewing is more sophisticated than health promotion via the provision of written, it still incorporates information provision as a core element. However, the pregnant woman is coached and guided towards finding information and solutions for themselves. This provides the pregnant woman with options, which increases the effectiveness of motivational interviewing in eliciting change behaviour. Choice is seen as an empowering tool that can secure continued commitment to change (i.e. sustained smoking cessation).

A strong feature of skill development and mastery is that coaches continually learn and hone their practice from direct client experience. Reflection on practice in peer, expert and line managerial supervision is possible using motivational interviewing quality audit tools such. (26)

In measuring the effectiveness of this programme of training, a number of outcomes require assessing. The impact of the training on skills development and confidence in utilising these skills requires assessment via interviews or questionnaires with professionals who attended the training. Ideally, this needs to be done pre-training and post-training, as well as 6-12 months later in order to assess the long-term sustainability of any new ways of working.

Patient records will also require examination in order to track the rates of smoking in pregnant women, as well as the number of quit attempts (both successful and unsuccessful). Abstinence can be measured via self-report and tests for carbon monoxide. Furthermore, the monitoring of adverse events related to smoking could provide useful information on the clinical benefits of the programme.

Importantly, patient-reported outcome data can be collected via anonymous questionnaires eliciting information on service user satisfaction with the skills of healthcare workers, the content of consultations, and the usefulness of the support provided for issues such as smoking cessation.

Overall, the design and delivery of a motivational interviewing training programme for healthcare professionals requires a multidisciplinary approach. In turn, the evaluation of the outcomes of the programme requires a whole-systems approach that takes into consideration both objective and subjective short- and long-term benefits to tackling the public health challenge of smoking in pregnancy.

References

Secretan B. A review of human carcinogens–Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncology 2009; 10(11): 1033-4.

Billaud N, Lemarie P. Negative effects of maternal smoking during the course of pregnancy. Archives de Pediatrie 2001; 8(8): 875-881.

Widerqe M, Vik T, Jacobsen G, Bakketeig LS. Does maternal smoking during pregnancy cause childhood overweight? Pediatric & Perinatal Epidemiology 2003; 17(2): 171.

United States Department of Health and Human Services. Women and Smoking: A Report of the Surgeon General. United States Department of Health and Human Services, Rockville, MD, 2001.

Centres for Disease Control and Prevention. Medical-care expenditures attributable to cigarette smoking during pregnancy-United States, 1995. JAMA 1997; 278: 2058-9.

NHS Centre for Reviews and Dissemination. Smoking cessation: what the health service can do. Effectiveness Matters 1998; 3: 1-4.

Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews 2001 ;(3):CD001056.

National Statistics. Statistics on smoking: England, 2006. The Information Centre, Lifestyle Statistics 2006.

West R. Smoking cessation and pregnancy. Fetal and Maternal Medicine Review 2002; 3:181-94.

Coulter A, Ellins J. Patient-focused Interventions: A review of the evidence. Picker Institute Europe and Health Foundation, 2006.

Rollnick S, Miller WR. What is motivational interviewing? Behavioural and Cognitive Psychotherapy 1995; 23: 325-334.

Prochaska JO, DiClemente C. Stages and processes of self-change of smoking: toward an integrative model of change. Journal of Consulting and Clinical Psychology 1983; 51(3): 390-395.

Munafò M, Mogg K, Roberts S, Bradley BP, Murphy M. Selective processing of smoking-related cues in current smokers, ex-smokers and never-smokers on the modified Stroop task. Journal of Psychopharmacology. 2003; 17:310-316.

Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. New York, Guilford Press, 2002.

Butler CC, Rollnick S, Cohen D. Motivational consulting versus brief advice for smokers in general practice: a randomised trial. British Journal of General Practice. 1999; 49: 611-616.

Hokanson JM, Anderson RL, Hennrikus DJ, Lando HA, Kendall DM. Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. The Diabetes Educator 2006; 32(4):562-70.

Bennett B, Sothern, MS. Diet, exercise, behavior: the promise and limits of Lifestyle change. Seminars in Pediatric Surgery 2009; 18: 152-158.

Hokanson JM, Anderson RL, Hennrikus DJ, Lando HA, Kendall DM. Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. The Diabetes Educator 2006; 32(4):562-70.

Karatay G, Kublay G, and Emiroglu ON. Effect of motivational interviewing on smoking cessation in pregnant women. Journal of Advanced Nursing 2010; 66(6): 1328-1337.

Ruger JP, Weinstein MC, Hammond SK, Kearney MH, Emmons KM. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: A randomized controlled trial. Value Health 2008; 11(2): 191-8.

Tappin DM, Lumsden MA, Gilmour WH. Randomised controlled trial of home based motivational interviewing by midwives to help pregnant smokers quit or cut down. BMJ 2005; 331: 373-7.

Soderlund LL, Madson MB, Rubak S, Nilsen P. A systematic review of motivational interviewing training for general health care practitioners. Patient Education and Counseling, 2010, in press.

Velasquez MM, Hecht J, Quinn VP, Emmons KM, DiClemente CC, Dolan-Mullen P. Application of motivational interviewing to prenatal smoking cessation: Training and implementation issues. Tobacco Control 2000;9 Suppl 3:III36-III40.

Hassel H, Rahden O. Training for midwives in motivational interviewing. Tailored intervention for smoking cessation in pregnancy. Journal of Public Health 2007; 15 (6): 441-445.

Rollnick S, Miller WR. What is motivational interviewing? Behavioural and Cognitive Psychotherapy 1995; 23: 325-334.

Glynn LH, Moyers TB. Chasing change talk: The clinician’s role in evoking client language about change. Journal of Substance Abuse Treatment 2010; 39(1): 65-70.

Essay on Parkinsons Disease

Parkinson’s Disease is the second most common neurodegenerative disease, after Alzheimer’s. Onset typically occurs late in life, affecting approximately 1% of 65 year olds, with the prevalence increasing to 4-5% by age 85 (Dawson & Dawson 2003). There are also rare cases of early-onset Parkinson’s, which are usually familial. Research into the gene mutations discovered in such hereditary cases has also contributed to the understanding of the aetiology of the spontaneous, late onset form of the disease.

Parkinson’s Disease (PD) is characterized clinically by tremors at rest, bradykinesia (slowness of voluntary movement), muscle rigidity, decrease in postural reflex and facial expression and an altered gait (Kumar et al. 2005). A subset of patients (10-15%) also develop dementia. Symptoms are progressive and result in decreased mobility and eventually severe disability.

The symptomatic motor disturbances arise from the progressive loss of dopaminergic neurons in the substantia nigra of the brain. This results in a decrease in the dopaminergic content of the striatum. These areas play an important role in modulating feedback from the thalamus to the motor cortex.

AIMS AND OBJECTIVES

This report aims to investigate the current knowledge of the aetiology of PD, by examining evidence in the literature. It is crucial to understand the pathological mechanisms underlying the selective destruction of dopaminergic neurons in PD so that effective treatments and prophylaxis can be developed.

PROPOSED STRATEGY

Researchers have studied the molecular mechanisms of PD pathogenesis using a number of techniques: in vitro tissue cultures of human and animal neurons, post-mortem human brain tissue, mouse models of the disease, genetic studies and more novel techniques such as the use of ‘cybrids’. Evidence from all of these will be amalgamated and conclusions drawn.

MOLECULAR PATHOGENESIS OF PD

That PD is generally associated with old age must be considered an important clue when trying to elucidate the causal mechanism of PD. The same is also true of the most common neurodegenerative disease, Alzheimer’s Disease (AD). Both are also characterised by an accumulation of protein aggregates resulting in progressive neuronal loss, suggesting a common underlying pathology.

Histological brain sections of PD patients shows characteristic, large inclusion bodies in the cytosol of surviving neurons of the substantia nigra, as well as locus ceruleus and surrounding brainstem nuclei, called Lewy bodies (Kumar et al. 2005). These are aggregates of -synuclein (Spillantini et al. 1997), a protein whose gene (SYN, aka PARK 1) has been linked to familial PD (Athanassiadou et al. 1999), as well as other proteins such as ubiquitin and synphilin-1. It is unclear whether these aggregates contribute to the pathogenesis, are a simple by-product or even part of an attempted protective mechanism, described as the aggresome theory (McNaught et al. 2002). Some evidence has recently been produced by Setsuie and colleagues (2005), using a PD rat model in which proteasome inhibitors caused inclusion formation, which resulted in decreased dopaminergic neuronal death that normally follows 6-hydroxyl dopamine (6-OHDA) administration.

Lewy bodies are also found in low numbers in normal aging and AD (Jellinger 2001). However, Lewy bodies are not found in some cases of juvenile onset PD, which suggests that the inclusions are not crucial for neuronal death in the substantia nigra (Fahn & Salzer 2004). Animal models of the disease, created using neurotoxins such as rotenone or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), or transgenic mice that overexpress human SYN gene (for -synuclein) mutations, do not faithfully replicate the structure and antigenicity of the Lewy bodies found in PD (Dickson 2001). This highlights the problems associated with designing and producing an accurate animal model of human disease, which can be valuable tools, despite some limitations.

Role of the ubiquitin-proteasome system (UPS)

Although the precise role of Lewy bodies in the pathogenesis of PD is still unclear, the accumulation and aggregation of proteins suggests that there is a deficit in the cellular systems that normally remove and degrade abnormal proteins. The ubiquitin-proteasome system (UPS) is one such pathway, and there is growing evidence that implicates this system in PD.

In conjunction with the enzymes E1, E2 and E3, ubiquitin is activated and attaches to abnormal proteins to form a polyubiquitin chain. The proteasome recognises this complex and degrades the unwanted protein. The ubiquitin polymer is released from the targeted protein and digested by ubiquitin carboxy-terminal hydroxylases (UCHs), to release ubiquitin monomers back into the system (Alberts et al. 2002). Ubiquitination and recognition of proteins to be degraded are ATP-dependent processes. If the activity of this clearance pathway decreases, misfolded or oxidatively damaged proteins will accumulate rather than being recycled (Sherman & Goldberg 2001).

Studies of the rarer, familial cases of PD have revealed evidence that this system is involved in PD aetiology, which has aided the understanding of the pathogenesis of sporadic PD. Gene mutations for two proteins that are involved in the UPS are of particular significance. Kitada and colleagues (1998) demonstrated a link between mutations in the

parkin

gene (aka PARK 2) and familial incidence of autosomal recessive juvenile parkinsonism (AR-JP) in Japanese families. Parkin is an E3 ligase within the UPS, and has been shown to have a neuroprotective role (Petrucelli et al. 2002). Despite this, parkin null-mutant mice exhibited normal behaviour and brain morphology, with no loss of dopaminergic neurons. Dopamine levels were altered, suggesting a possible role in dopamine regulation (Goldberg et al. 2003).

Drosophila

parkin null-mutants showed a consistent pattern of pathology, with locomotor deficits, sterility and decreased lifespan (Greene et al. 2003). These were attributed to mitochondrial dysfunction, which is also a feature of PD (see below). Research into the potential toxic effects of accumulation of parkin substrates has been inconclusive (Betarbet et al. 2005). Evidence points to parkin involvement in the pathogenesis of PD, but mutations of this protein are not sufficient alone to cause the disease.

A missense mutation for the gene encoding the protein UCH-L1 has been detected in autosomal dominant familial cases of PD in Germany (Leroy et al. 1998). In sporadic cases of PD, UCH-L1 is downregulated and oxidized in the cerebral cortex (Choi et al. 2004), the significance of this is unknown.

UCH-L1

mutations in mice produce neuromotor signs that are not typical of PD, and are characterised as Gracile Axonal Dystrophy mice (GAD). As for parkin, the evidence confirms some involvement in PD pathogenesis of these elements of the UPS, but points to the need for further research to fully deduce their role.

Other genetic mutations have been identified, such as LRRK2 (a kinase;Zimprich et al. 2004) and DJ-1 (aka PARK 7), which is involved in a similar protein degradation pathway (SUMO; Bonifati et al. 2003).

It is tempting to attribute the accumulation of -synuclein to a decrease in activity of the UPS, but evidence that -synuclein is a substrate of this system is contradictory (Paxinou et al. 2001), with results differing between

in vitro

cell lines and conditions. Some studies suggest that -synuclein accumulation may inhibit the UPS, resulting in further protein accumulation (Liu et al. 2005).

Role of mitochondrial dysfunction and oxidative stress

A significant amount of evidence supports the hypothesis of involvement of the UPS in PD aetiology. In familial cases genetic mutations have been discovered that account for a portion of the susceptibility to, and pathogenesis of PD; but other factors are obviously required for both early onset and sporadic cases to develop. UPS activity has been found to be lowered in sporadic PD patients, with impaired proteasomal activity and reduced expression of subunits in the substantia nigra (McNaught et al. 2003). Whether UPS impairment is a primary cause or secondary to another event is not yet clear. Some researchers believe that the mechanism underlying the dysfunctional UPS may involve mitochondrial dysfunction, which has also been implicated in other neurodegenerative diseases (Hashimoto et al. 2003). During energy production by respiration in the mitochondria, there is a continuous leakage of free radicals, such as reactive oxygen species (ROS), which are also released by inflammatory cells. Antioxidant mechanisms exist to mop these up before they can cause oxidative damage to surrounding molecules, such as proteins, lipids and DNA, but these are not 100% efficient. This results in a gradual increase in damaged cellular components with aging (Vigoroux et al. 2004). Higher levels of oxidization products have been found in brain tissue of patients with neurodegenerative diseases such as PD (Dexter et al. 1994) and suggest an important role for free radicals in its aetiology. Mitochondrial DNA (mtDNA) damage has been hypothesised to accumulate, leading eventually to mitochondrial dysfunction, which further increases free radical leakage. Mitochondrial complex I, in particular, has been implicated. Induced parkinsonism in animal models using the pesticide rotenone has been shown to inhibit mitochondrial complex I (Sherer et al. 2002). Administration of MPTP also induces PD symptoms and inclusion body formation, via the complex I inhibition of its metabolite MPP+ (Ramsay et al. 1986). This has been recorded in human subjects following the use of illicitly manufactured narcotics, in which MPTP is produced as a contaminant, but has now been used to reliably induce disease in rodents to further knowledge of the pathogenesis of this disease. As well as providing valuable insights into the mechanisms underlying PD, the ability of chemicals to produce the symptoms and pathology of PD has also raised concerns about the role of environmental factors in the aetiology of the sporadic disease. Some epidemiological studies have linked pesticide exposure to an increased risk of developing PD (Park et al. 2005), as well as suggestions that increased coffee/caffeine consumption and smoking (Wirdefeldt et al. 2005) may have some protective benefits. Exposure to heavy metals, such as manganese has also shown a correlation with PD in some studies, but not all. Heavy metals are known to accelerate free radical formation and hence increase oxidative stress, so it would not be unexpected if higher levels were involved in PD aetiology. Results of epidemiological studies that claim to prove these positive and negative correlations with PD are contradictory, and further research is required, which could also take diet into account (particularly ingested antioxidant levels and lifestyle).

Mitochondrial dysfunction may cause a decrease in UPS activity, either by reduced ATP production, which is essential for many processes of the pathway, and/or by increasing oxidative stress and damaging vital components of the system (Fahn & Salzer 2004). The pivotal role of mitochondria has been elegantly demonstrated by the use of cytoplasmic hybrids. These ‘cybrids’ are formed by taking mtDNA from platelets of patients with PD and inserting it into cultured human neuroblastoma cells that have been depleted of their endogenous mtDNA. These neuronal cells faithfully recapitulate the structure and antigenicity of Lewy bodies (Trimmer et al. 2004), and similar studies have reported other pathogenic features consistent with a role for mitochondria and oxidative stress in PD.

It is now widely accepted that oxidative stress is a contributory factor to PD aetiology, with markers of oxidative damage found to be higher than in non-PD controls.

Antioxidants have been administered in a number of studies to further explore the impact of free radicals and therapeutic/prophylactic options. Transgenic mice that overexpress the endogenous antioxidant Cu,Zn-superoxide dismutase did not show any symptoms or DA neuron loss following exposure to paraquat (herbicide)-maneb (fungicide), compared to non-transgenic controls (Thiruchelvam et al. 2005). Studies involving exogenous antioxidants have produced inconclusive results, and more research is required in this area.

The specificity of dopaminergic neuronal loss, mainly in the substantia nigra pars compacta, in PD is replicated in chemically induced animal models of disease. The reason for this consistent and specific pattern of neuropathology may be due to the oxidation properties of DA, with highly reactive DA-quinones being generated. These are able to form complexes with -synuclein and may inhibit mitochondrial complex I (Asanuma et al. 2003). This has important implications for the commonly used L-DOPA therapy, which may also contribute to neurodegeneration.

Some researchers also believe that inflammation may play a role in PD, as microglial cells proliferate in affected brain regions (McGeer & McGeer 2004).

CONCLUSION

The aetiology of Parkinson’s Disease is multifactorial, with a combination of genetic, environmental and possibly immunological factors, many of which are still unknown or poorly understood. There is growing evidence from a variety of research techniques that oxidative stress, mitochondrial dysfunction and deficits in protein degradation pathways, such as the UPS are interlinked. The aetiological factors initiate a process that culminates in the accumulation and aggregation of proteins, mainly -synuclein, in dopaminergic neurons of the nigrostriatal system, which leads to cell-death. Further research is required to fully elucidate the precise molecular mechanisms that underlie the neuropathology of PD, so that effective treatments or prophylactic advice can be established.

Related content

REFERENCES

  • Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, Molecular Biology of the Cell. 4th Ed. New York:

    Garland Publishing

    . pp.359-363.
  • Asanuma, M., Miyazaki, I. & Ogawa, N. 2003 Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease.

    Neurotox Res


    5

    , 165-76.
  • Athanassiadou, A., Voutsinas, G., Psiouri, L., Leroy, E., Polymeropoulos, M. H., Ilias, A., Maniatis, G. M. & Papapetropoulos, T. 1999 Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.

    Am J Hum Genet


    65

    , 555-8.
  • Betarbet, R., Sherer, T. B. & Greenamyre, J. T. 2005 Ubiquitin-proteasome system and Parkinson’s diseases.

    Exp Neurol


    191 Suppl 1

    , S17-27.
  • Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L. S. & Li, L. 2004 Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson’s and Alzheimer’s diseases.

    J Biol Chem


    279

    , 13256-64.
  • Dawson, T. M. & Dawson, V. L. 2003 Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

    J Clin Invest


    111

    , 145-51.
  • Dexter, D. T., Holley, A. E., Flitter, W. D., Slater, T. F., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P. & Marsden, C. D. 1994 Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.

    Mov Disord


    9

    , 92-7.
  • Dickson, D. W. 2001 Alpha-synuclein and the Lewy body disorders.

    Curr Opin Neurol


    14

    , 423-32.
  • Fahn, S. & Sulzer, D. 2004 Neurodegeneration and Neuroprotection in Parkinson Disease.

    Neurorx


    1

    , 139-154.
  • Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., Gajendiran, M., Roth, B. L., Chesselet, M. F., Maidment, N. T., Levine, M. S. & Shen, J. 2003 Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.

    J Biol Chem


    278

    , 43628-35.
  • Hashimoto, M., Rockenstein, E., Crews, L. & Masliah, E. 2003 Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases.

    Neuromolecular Med


    4

    , 21-36.
  • Jellinger, K. A. 2001 The pathology of Parkinson’s disease.

    Adv Neurol


    86

    , 55-72.
  • Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. & Shimizu, N. 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

    Nature


    392

    , 605-8.
  • Kumar, V., Abbas, A.K., Fausto, N. 2005 Chapter 13. In

    Robbins Pathologic Basis of Disease

    . Pennsylvania, USA: Elsevier Saunders.
  • Leroy, E., Boyer, R. & Polymeropoulos, M. H. 1998 Intron-exon structure of ubiquitin c-terminal hydrolase-L1.

    DNA Res


    5

    , 397-400.
  • Liu, C. W., Giasson, B. I., Lewis, K. A., Lee, V. M., Demartino, G. N. & Thomas, P. J. 2005 A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson’s disease.

    J Biol Chem

    .
  • McGeer, P. L. & McGeer, E. G. 2004 Inflammation and neurodegeneration in Parkinson’s disease.

    Parkinsonism Relat Disord


    10 Suppl 1

    , S3-7.
  • McNaught, K. S., Belizaire, R., Isacson, O., Jenner, P. & Olanow, C. W. 2003 Altered proteasomal function in sporadic Parkinson’s disease.

    Exp Neurol


    179

    , 38-46.
  • McNaught, K. S., Shashidharan, P., Perl, D. P., Jenner, P. & Olanow, C. W. 2002 Aggresome-related biogenesis of Lewy bodies.

    Eur J Neurosci


    16

    , 2136-48.
  • Park, J., Yoo, C. I., Sim, C. S., Kim, H. K., Kim, J. W., Jeon, B. S., Kim, K. R., Bang, O. Y., Lee, W. Y., Yi, Y., Jung, K. Y., Chung, S. E. & Kim, Y. 2005 Occupations and Parkinson’s disease: a multi-center case-control study in South Korea.

    Neurotoxicology


    26

    , 99-105.
  • Paxinou, E., Chen, Q., Weisse, M., Giasson, B. I., Norris, E. H., Rueter, S. M., Trojanowski, J. Q., Lee, V. M. & Ischiropoulos, H. 2001 Induction of alpha-synuclein aggregation by intracellular nitrative insult.

    J Neurosci


    21

    , 8053-61.
  • Petrucelli, L., O’Farrell, C., Lockhart, P. J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J. & Cookson, M. R. 2002 Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.

    Neuron


    36

    , 1007-19.
  • Ramsay, R. R., Dadgar, J., Trevor, A. & Singer, T. P. 1986 Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.

    Life Sci


    39

    , 581-8.
  • Setsuie, R., Kabuta, T. & Wada, K. 2005 Does proteosome inhibition decrease or accelerate toxin-induced dopaminergic neurodegeneration?

    J Pharmacol Sci


    97

    , 457-60.
  • Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R. & Greenamyre, J. T. 2002 An in vitro model of Parkinson’s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

    J Neurosci


    22

    , 7006-15.
  • Sherman, M. Y. & Goldberg, A. L. 2001 Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.

    Neuron


    29

    , 15-32.
  • Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. & Goedert, M. 1997 Alpha-synuclein in Lewy bodies.

    Nature


    388

    , 839-40.
  • Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D. A., Richfield, E. K., Buckley, B. & Mirochnitchenko, O. 2005 Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat+maneb-induced Parkinson’s disease phenotype.

    J Biol Chem

    .
  • Trimmer, P. A., Keeney, P. M., Borland, M. K., Simon, F. A., Almeida, J., Swerdlow, R. H., Parks, J. P., Parker, W. D., Jr. & Bennett, J. P., Jr. 2004 Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer’s disease worsen with passage in culture.

    Neurobiol Dis


    15

    , 29-39.
  • Vigouroux, S., Briand, M. & Briand, Y. 2004 Linkage between the proteasome pathway and neurodegenerative diseases and aging.

    Mol Neurobiol


    30

    , 201-21.
  • Wirdefeldt, K., Gatz, M., Pawitan, Y. & Pedersen, N. L. 2005 Risk and protective factors for Parkinson’s disease: a study in Swedish twins.

    Ann Neurol


    57

    , 27-33.
  • Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., Stoessl, A. J., Pfeiffer, R. F., Patenge, N., Carbajal, I. C., Vieregge, P., Asmus, F., Muller-Myhsok, B., Dickson, D. W., Meitinger, T., Strom, T. M., Wszolek, Z. K. & Gasser, T. 2004 Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

    Neuron


    44

    , 601-7.